Recombinant respiratory syncytial virus vaccine( (CHO Cell)) (Varnotech Biopharm)

重组呼吸道合胞病毒疫苗（CHO细胞）（华诺泰生物）

Report date: 2025/11/06 11:27:40

Base Information

Drug NameRecombinant respiratory syncytial virus vaccine( (CHO Cell)) (Varnotech Biopharm)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Varnotech Biopharm Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Varnotech Biopharm Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A